19-10315310-A-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001397406.1(FDX2):c.307+76T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 23)
Exomes 𝑓: 0.0000016 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
FDX2
NM_001397406.1 intron
NM_001397406.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.125
Publications
5 publications found
Genes affected
FDX2 (HGNC:30546): (ferredoxin 2) This gene encodes a member of the ferredoxin family. The encoded protein contains a 2Fe-2S ferredoxin-type domain and is essential for heme A and Fe/S protein biosynthesis. Mutation in FDX1L gene is associated with mitochondrial muscle myopathy. [provided by RefSeq, Sep 2014]
FDX2 Gene-Disease associations (from GenCC):
- mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathyInheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FDX2 | ENST00000393708.3 | c.307+76T>A | intron_variant | Intron 3 of 4 | 1 | NM_001397406.1 | ENSP00000377311.5 | |||
| ENSG00000167807 | ENST00000452032.6 | n.307+76T>A | intron_variant | Intron 3 of 10 | 2 | ENSP00000408510.3 | ||||
| ENSG00000267303 | ENST00000586529.1 | n.*1537T>A | downstream_gene_variant | 5 | ENSP00000467814.1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 144778Hom.: 0 Cov.: 23
GnomAD3 genomes
AF:
AC:
0
AN:
144778
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000160 AC: 1AN: 626070Hom.: 0 Cov.: 9 AF XY: 0.00 AC XY: 0AN XY: 317872 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
626070
Hom.:
Cov.:
9
AF XY:
AC XY:
0
AN XY:
317872
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
14900
American (AMR)
AF:
AC:
0
AN:
17470
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
14662
East Asian (EAS)
AF:
AC:
0
AN:
29368
South Asian (SAS)
AF:
AC:
0
AN:
43266
European-Finnish (FIN)
AF:
AC:
0
AN:
27412
Middle Eastern (MID)
AF:
AC:
0
AN:
2366
European-Non Finnish (NFE)
AF:
AC:
1
AN:
446162
Other (OTH)
AF:
AC:
0
AN:
30464
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 144800Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 69808
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
144800
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
69808
African (AFR)
AF:
AC:
0
AN:
39240
American (AMR)
AF:
AC:
0
AN:
14372
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3434
East Asian (EAS)
AF:
AC:
0
AN:
4900
South Asian (SAS)
AF:
AC:
0
AN:
4640
European-Finnish (FIN)
AF:
AC:
0
AN:
8390
Middle Eastern (MID)
AF:
AC:
0
AN:
280
European-Non Finnish (NFE)
AF:
AC:
0
AN:
66636
Other (OTH)
AF:
AC:
0
AN:
2016
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.